These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 10810442)

  • 21. [Apoptosis and uterine cervical carcinogenesis].
    Yao J; Lin H; Song H
    Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):480-2. PubMed ID: 11235569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
    Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
    Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck.
    Riedel F; Götte K; Bergler W; Hörmann K
    Oncol Rep; 2001; 8(3):471-6. PubMed ID: 11295065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.
    Sivridis E; Giatromanolaki A; Anastasiadis P; Georgiou L; Gatter KC; Harris AL; Bicknell R; Koukourakis MI;
    J Pathol; 2002 Apr; 196(4):416-22. PubMed ID: 11920737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome.
    Hawighorst H; Weikel W; Knapstein PG; Knopp MV; Zuna I; Schönberg SO; Vaupel P; van Kaick G
    Clin Cancer Res; 1998 Oct; 4(10):2305-12. PubMed ID: 9796959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer.
    Obermair A; Kohlberger P; Bancher-Todesca D; Tempfer C; Sliutz G; Leodolter S; Reinthaller A; Kainz C; Breitenecker G; Gitsch G
    Gynecol Oncol; 1996 Nov; 63(2):204-9. PubMed ID: 8910628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
    Liu R; Pu DM; Cheng YX; Yin L
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between spontaneous apoptosis and the expression of angiogenic factors in advanced gastric adenocarcinoma.
    Ikeguchi M; Cai J; Fukuda K; Oka S; Katano K; Tsujitani S; Maeta M; Kaibara N
    J Exp Clin Cancer Res; 2001 Jun; 20(2):257-63. PubMed ID: 11484984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
    Hague S; Zhang L; Oehler MK; Manek S; MacKenzie IZ; Bicknell R; Rees MC
    Clin Cancer Res; 2000 Jul; 6(7):2808-14. PubMed ID: 10914728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microvessel density (MVD) and vascular endothelial growth factor expression (VEGF) in human oral squamous cell carcinoma.
    Artese L; Rubini C; Ferrero G; Fioroni M; Santinelli A; Piattelli A
    Anticancer Res; 2001; 21(1B):689-95. PubMed ID: 11299827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor in canine cutaneous fibrosarcomas.
    Al-Dissi AN; Haines DM; Singh B; Kidney BA
    J Comp Pathol; 2009 Nov; 141(4):229-36. PubMed ID: 19560781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of angiogenesis in nonsmall-cell lung carcinoma.
    Offersen BV; Pfeiffer P; Hamilton-Dutoit S; Overgaard J
    Cancer; 2001 Apr; 91(8):1500-9. PubMed ID: 11301398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas.
    Li C; Shintani S; Terakado N; Klosek SK; Ishikawa T; Nakashiro K; Hamakawa H
    Int J Oral Maxillofac Surg; 2005 Jul; 34(5):559-65. PubMed ID: 16053878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis.
    Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
    Cancer Lett; 2004 May; 208(2):215-25. PubMed ID: 15142681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.